EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rifampicin Repurposing Reveals Anti-Melanogenic Activity in B16F10 Melanoma Cells

Ye-Jin Lee iD, Chang-Gu Hyun iD

Molecules · 2025

DOI: 10.3390/molecules30040900 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Ye-Jin Lee und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Cosmetics, Jeju Inside Agency and Cosmetic Science Center, Jeju National University, Jeju 63243, Republic of Korea. Hauptthemen laut MEDLINE: Rifampin, Drug Repositioning, Melanins, Melanoma, Experimental. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jeju National University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug repurposing is a cost-effective and innovative strategy for identifying new therapeutic applications for existing drugs, thereby shortening development timelines and accelerating the availability of treatments. Applying this approach to the development of cosmeceutical ingredients enables the creation of functional compounds with proven safety and efficacy, adding significant value to the cosmetic industry. This study evaluated the potential of rifampicin, a drug widely used for the treatment of tuberculosis and leprosy, as a cosmeceutical agent. The anti-melanogenic effects of rifampicin were assessed in B16F10 melanoma cells, showing no cytotoxicity at concentrations up to 40 µM and a significant reduction in intracellular tyrosinase activity and melanin content. Mechanistically, rifampicin reduced the expression of melanogenic enzymes, including tyrosinase, tyrosinase-related protein (TRP)-1, and TRP-2, via a protein kinase A (PKA)-dependent pathway, leading to the suppression of microphthalmia-associated transcription factor (MITF), which is a key regulator of melanogenesis. Additionally, rifampicin inhibited the p38 signaling pathway but was independent of the PI3K/protein kinase B (Akt) pathway. Furthermore, it decreased Ser9 phosphorylation, enhancing glycogen synthase kinase-3β (GSK-3β) activity, promoted β-catenin phosphorylation, and facilitated β-catenin degradation, collectively contributing to the inhibition of melanin synthesis. To evaluate the topical applicability of rifampicin, primary human skin irritation tests were conducted, and no adverse effects were observed at concentrations of 20 µM and 40 µM. These findings demonstrate that rifampicin inhibits melanogenesis through multiple signaling pathways, including PKA, MAPKs, and GSK-3β/β-catenin. This study highlights the potential of rifampicin to be repurposed as a topical agent for managing hyperpigmentation disorders, offering valuable insights into novel therapeutic strategies for pigmentation-related conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RifampinDrug RepositioningMelaninsMelanoma, ExperimentalMiceAnimalsCell Line, TumorMicrophthalmia-Associated Transcription FactorMonophenol MonooxygenaseSignal TransductionHumansOxidoreductasesCyclic AMP-Dependent Protein KinasesCell Survival

Stichwörter der Autor:innen

B16F10PI3K/Akt pathwayPKA pathwaycosmeceuticaldrug repurposinghyperpigmentationmelanogenesisrifampicinβ-catenin

Substanzen

RifampinMelaninsMicrophthalmia-Associated Transcription FactorMonophenol MonooxygenaseOxidoreductasesCyclic AMP-Dependent Protein Kinases

Autor:innen und Institutionen

  • Department of Chemistry and Cosmetics, Jeju Inside Agency and Cosmetic Science Center, Jeju National University, Jeju 63243, Republic of Korea.

ORCID-Profile: Ye-Jin Lee, Chang-Gu Hyun

Förderung

  • Jeju National University

Zitieren

APA

Lee, Y. J., & Hyun, C. G. (2025). Rifampicin Repurposing Reveals Anti-Melanogenic Activity in B16F10 Melanoma Cells. Molecules. https://doi.org/10.3390/molecules30040900

Vancouver

Lee YJ, Hyun CG. Rifampicin Repurposing Reveals Anti-Melanogenic Activity in B16F10 Melanoma Cells. Molecules. 2025. doi:10.3390/molecules30040900

BibTeX
@article{Lee2025,
  author = {Lee, Ye-Jin and Hyun, Chang-Gu},
  title = {Rifampicin Repurposing Reveals Anti-Melanogenic Activity in B16F10 Melanoma Cells},
  journal = {Molecules},
  year = {2025},
  doi = {10.3390/molecules30040900}
}
Kostenlos starten →